A detailed history of Los Angeles Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 209,795 shares of INCY stock, worth $14.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
209,795
Previous 370,411 43.36%
Holding current value
$14.4 Million
Previous $22.5 Million 38.24%
% of portfolio
0.06%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$57.33 - $68.61 $9.21 Million - $11 Million
-160,616 Reduced 43.36%
209,795 $13.9 Million
Q2 2024

Aug 05, 2024

SELL
$51.18 - $63.75 $59.9 Million - $74.6 Million
-1,170,045 Reduced 75.95%
370,411 $22.5 Million
Q1 2024

Apr 05, 2024

SELL
$56.55 - $66.59 $1.69 Million - $1.99 Million
-29,840 Reduced 1.9%
1,540,456 $87.8 Million
Q4 2023

Feb 06, 2024

BUY
$52.16 - $64.19 $22.2 Million - $27.3 Million
424,934 Added 37.1%
1,570,296 $98.6 Million
Q3 2023

Nov 06, 2023

BUY
$57.77 - $65.93 $56.5 Million - $64.5 Million
978,342 Added 585.76%
1,145,362 $66.2 Million
Q2 2023

Aug 03, 2023

SELL
$60.95 - $75.51 $29.3 Million - $36.3 Million
-480,402 Reduced 74.2%
167,020 $10.4 Million
Q1 2023

May 04, 2023

BUY
$70.23 - $86.01 $1.07 Million - $1.31 Million
15,230 Added 2.41%
647,422 $46.8 Million
Q4 2022

Feb 06, 2023

BUY
$67.18 - $84.11 $8.33 Million - $10.4 Million
124,005 Added 24.4%
632,192 $50.8 Million
Q3 2022

Nov 02, 2022

BUY
$66.18 - $82.86 $14.7 Million - $18.4 Million
221,519 Added 77.27%
508,187 $33.9 Million
Q2 2022

Aug 05, 2022

SELL
$66.18 - $83.18 $7.2 Million - $9.04 Million
-108,724 Reduced 27.5%
286,668 $21.8 Million
Q1 2022

May 06, 2022

SELL
$66.02 - $79.71 $26.4 Million - $31.9 Million
-400,520 Reduced 50.32%
395,392 $31.4 Million
Q4 2021

Feb 03, 2022

BUY
$63.34 - $74.11 $48.8 Million - $57.1 Million
770,736 Added 3061.39%
795,912 $58.4 Million
Q3 2021

Nov 08, 2021

BUY
$68.67 - $84.02 $1.73 Million - $2.12 Million
25,176 New
25,176 $1.73 Million
Q2 2021

Aug 05, 2021

SELL
$79.87 - $87.53 $1.35 Million - $1.48 Million
-16,923 Closed
0 $0
Q1 2021

May 05, 2021

SELL
$76.02 - $100.5 $237,410 - $313,861
-3,123 Reduced 15.58%
16,923 $0
Q4 2020

Feb 04, 2021

SELL
$80.74 - $97.7 $990,922 - $1.2 Million
-12,273 Reduced 37.97%
20,046 $1.74 Million
Q3 2020

Nov 02, 2020

SELL
$85.07 - $109.69 $12.7 Million - $16.4 Million
-149,864 Reduced 82.26%
32,319 $2.9 Million
Q2 2020

Aug 05, 2020

SELL
$74.18 - $108.93 $65.5 Million - $96.2 Million
-882,722 Reduced 82.89%
182,183 $0
Q1 2020

May 04, 2020

SELL
$63.18 - $85.97 $14.6 Million - $19.8 Million
-230,596 Reduced 17.8%
1,064,905 $78 Million
Q4 2019

Feb 07, 2020

BUY
$73.04 - $95.72 $33.9 Million - $44.5 Million
464,473 Added 55.89%
1,295,501 $113 Million
Q3 2019

Nov 07, 2019

BUY
$72.82 - $86.52 $60.2 Million - $71.5 Million
826,767 Added 19403.12%
831,028 $61.7 Million
Q2 2019

Jul 29, 2019

SELL
$73.52 - $88.7 $4.85 Million - $5.85 Million
-65,902 Reduced 93.93%
4,261 $362,000
Q1 2019

Apr 25, 2019

BUY
$63.56 - $88.17 $1.66 Million - $2.3 Million
26,120 Added 59.31%
70,163 $6.04 Million
Q4 2018

Feb 11, 2019

SELL
$58.5 - $69.94 $2.73 Million - $3.27 Million
-46,710 Reduced 51.47%
44,043 $2.8 Million
Q3 2018

Nov 05, 2018

BUY
$61.75 - $74.23 $1.81 Million - $2.17 Million
29,300 Added 47.68%
90,753 $6.27 Million
Q2 2018

Jul 31, 2018

BUY
$60.85 - $83.98 $356,885 - $492,542
5,865 Added 10.55%
61,453 $4.12 Million
Q1 2018

Apr 27, 2018

SELL
$83.06 - $100.98 $1.27 Million - $1.54 Million
-15,260 Reduced 21.54%
55,588 $4.63 Million
Q4 2017

Feb 05, 2018

BUY
$93.56 - $116.6 $4.49 Million - $5.6 Million
48,032 Added 210.52%
70,848 $6.71 Million
Q3 2017

Nov 06, 2017

BUY
$109.15 - $138.27 $290,339 - $367,798
2,660 Added 13.2%
22,816 $2.66 Million
Q2 2017

Aug 09, 2017

BUY
N/A
20,156
20,156 $2.54 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.